Safety in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 vs. Placebo, DB, Parallel Group, Randomized, Insulin Background Inclusive
收藏DataCite Commons2025-12-08 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00003549/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
to determine safety, efficacy and tolerability of BI 1356 versus placebo
提供机构：
Vivli
创建时间：
2019-04-12
